---
figid: PMC7151331__geriatrics-05-00018-g006
figtitle: Normal Vitamin K cycle vs
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC7151331
filename: geriatrics-05-00018-g006.jpg
figlink: pmc/articles/PMC7151331/figure/geriatrics-05-00018-f006/
number: F6
caption: Normal Vitamin K cycle vs. Vitamin K antagonist. Compared to the normal pathway
  on the left, warfarin is reduced by Vitamin K epoxide reductase and quinone reductase
  preventing the regeneration of Vitamin K and subsequent carboxylation of coagulation
  factors.
papertitle: Review of Therapeutic Options for the Prevention of VTE in Total Joint
  Arthroplasty.
reftext: Jordan Etscheidt, et al. Geriatrics (Basel). 2020 Mar;5(1):18.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6235198
figid_alias: PMC7151331__F6
figtype: Figure
redirect_from: /figures/PMC7151331__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7151331__geriatrics-05-00018-g006.html
  '@type': Dataset
  description: Normal Vitamin K cycle vs. Vitamin K antagonist. Compared to the normal
    pathway on the left, warfarin is reduced by Vitamin K epoxide reductase and quinone
    reductase preventing the regeneration of Vitamin K and subsequent carboxylation
    of coagulation factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Warfarin-S-S
  - Vitamin K
  - hydroquinone
  - Warfarin
  - NAD(P)+
  - Quinone
  - NADP
  - NAD(P)H
  - Vitamin K quninone
  - epoxide
  - Warfarin-SH-SH
---
